Karen Finerman has been president of Metropolitan Capital Advisors Inc. since 1992 when she co-founded the firm. Prior to June 1992, she was the lead research analyst for the Risk Arbitrage department at Donaldson, Lufkin & Jenrette Securities Corporation.
She received a B.S. in economics from the University of Pennsylvania's Wharton School in 1987, with a concentration in finance.
Finerman is on the board of the Michael J. Fox Foundation for Parkinson's Research and is also a trustee of the Montefiore Medical Center in the Bronx, N.Y., where she serves on their investment committee.
Follow Karen Finerman on Twitter @karenfinerman.
You know the OptionMonster loves Akamai and F5. But unusual options action led Pete Najarian to put 3 other names on his radar. Should they be on yours?
The UBS analyst who downgraded Intel explains his action and what the stock needs to turnaround.